PBMs

For two decades, patients and physicians eagerly awaited a lower-cost version of the world’s bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around…

Major stakeholders in the pharmaceutical industry on Wednesday testified in front of a key Senate panel to address questions over the affordability of insulin, with the assembled witnesses, as expected, passing the blame amongst each…

WASHINGTON, DC - MARCH 22: Senate Health, Education, Labor, and Pensions Committee Chairman Bernie ... Sanders (I-VT) delivers opening remarks during a hearing with Moderna CEO Stephane Bancel in the Hart Senate Office Building on Capitol…

Senator Maria Cantwell is a Democrat from the state of Washington and chair of the Senate Commerce, ... Science and Transportation Committee. Photographer: Nathan Howard/Bloomberg © 2023 Bloomberg Finance LP The pressure on pharmacy…

In January, drug makers announce increases in list prices of drugs, which can negatively impact ... patients. Health insurers and pharmacy benefit managers also implement changes in drug coverage, to the detriment of patients.getty…

FILE - As of January 31st, 2023, Humira finally faces competition in the U.S. as the first ... Humira-referenced biosimilar, Amjevita (adalimumab-atto) launches. (AP Photo/David J. Phillip, File)Copyright 2016 The Associated Press. All…

In 2023, let's start building a better healthcare system that has the patient as its focal point.getty Previously this month, I gave predictions for 2023. Here, I’ll offer some aspirations for the healthcare system in 2023: What I hope to…

This two-part article was researched and written in partnership with Cathy DuRei, President of Rumbly Health. If, as Mitt Romney said, a corporation is a person, then is it akin to murder if an idea takes down a company? What about if it…